Clinical Trial Update: OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study) [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic/pharmacodynamic trial evaluated crushed and dispersed ticagrelor 180 mg versus whole-tablet ticagrelor at the same dose in STEMI patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: ST Elevation Myocardial Infarction | Phase 4 | Status: COMPLETED